Key Takeaway: Turn Therapeutics celebrated its first day of trading on Nasdaq by ringing the Closing Bell. Founder and CEO Bradley Burnam reflected on the company's journey from humble beginnings to a public trading entity. The event highlights the company's growth and success in the biopharma sector.
Price reaction · baseline $9.2 (2025-10-09 close) · hit after-hours · 3 other TTRX headline(s) in the window, move may be shared
day 0 close
-19%
day 1
-29.2%
day 3 · peak
-44.6%
Market Sentiment Analysis
POSITIVE FACTORS
Celebration of Turn Therapeutics' first day on Nasdaq.
Founder/CEO shared an inspiring company journey.
Public recognition through the Nasdaq Closing Bell.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Cash runway
~32 mo
Minimal dilution risk
Lead asset
GX-03
Phase 2 · Covid19
Full Press Release Details
Turn Therapeutics ($TTRX) was invited to ring the “Closing Bell” to celebrate our first day of trading on Nasdaq. Our Founder/CEO Bradley Burnam spoke of the company’s journey “from the garage floor to the trading floor.”
Replay the full recording of the livestream aired on October 8th, 2025.
Frequently Asked Questions
What event did Turn Therapeutics celebrate?
Turn Therapeutics celebrated its first day of trading on Nasdaq.
Who spoke at the Nasdaq Closing Bell event?
Founder and CEO Bradley Burnam spoke at the event.
When did Turn Therapeutics ring the Closing Bell?
Turn Therapeutics rang the Closing Bell on October 8th, 2025.
What was the theme of Bradley Burnam's speech?
He spoke about the company's journey from the garage floor to the trading floor.